Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages
- PMID: 33208487
- PMCID: PMC7818336
- DOI: 10.2337/dc20-2192
Incremental Risk of Developing Severe COVID-19 Among Mexican Patients With Diabetes Attributed to Social and Health Care Access Disadvantages
Abstract
Objective: Diabetes is an important risk factor for severe coronavirus disease 2019 (COVID-19), but little is known about the marginal effect of additional risk factors for severe COVID-19 among individuals with diabetes. We tested the hypothesis that sociodemographic, access to health care, and presentation to care characteristics among individuals with diabetes in Mexico confer an additional risk of hospitalization with COVID-19.
Research design and methods: We conducted a cross-sectional study using public data from the General Directorate of Epidemiology of the Mexican Ministry of Health. We included individuals with laboratory-confirmed severe acute respiratory syndrome coronavirus 2 between 1 March and 31 July 2020. The primary outcome was the predicted probability of hospitalization, inclusive of 8.5% of patients who required intensive care unit admission.
Results: Among 373,963 adults with COVID-19, 16.1% (95% CI 16.0-16.3) self-reported diabetes. The predicted probability of hospitalization was 38.4% (37.6-39.2) for patients with diabetes only and 42.9% (42.2-43.7) for patients with diabetes and one or more comorbidities (obesity, hypertension, cardiovascular disease, and chronic kidney disease). High municipality-level of social deprivation and low state-level health care resources were associated with a 9.5% (6.3-12.7) and 17.5% (14.5-20.4) increased probability of hospitalization among patients with diabetes, respectively. In age-, sex-, and comorbidity-adjusted models, living in a context of high social vulnerability and low health care resources was associated with the highest predicted probability of hospitalization.
Conclusions: Social vulnerability contributes considerably to the probability of hospitalization among individuals with COVID-19 and diabetes with associated comorbidities. These findings can inform mitigation strategies for populations at the highest risk of severe COVID-19.
© 2020 by the American Diabetes Association.
Figures



Similar articles
-
Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.Public Health. 2020 Dec;189:66-72. doi: 10.1016/j.puhe.2020.09.014. Epub 2020 Sep 30. Public Health. 2020. PMID: 33166857 Free PMC article.
-
Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.JAMA Netw Open. 2020 Oct 1;3(10):e2025197. doi: 10.1001/jamanetworkopen.2020.25197. JAMA Netw Open. 2020. PMID: 33084902 Free PMC article.
-
Association between body-mass index, patient characteristics, and obesity-related comorbidities among COVID-19 patients: A prospective cohort study.Obes Res Clin Pract. 2023 Jan-Feb;17(1):47-57. doi: 10.1016/j.orcp.2022.12.003. Epub 2022 Dec 20. Obes Res Clin Pract. 2023. PMID: 36577559 Free PMC article.
-
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.JAMA Netw Open. 2020 Jun 1;3(6):e2012270. doi: 10.1001/jamanetworkopen.2020.12270. JAMA Netw Open. 2020. PMID: 32543702 Free PMC article. Review.
-
Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.Chest. 2021 Feb;159(2):524-536. doi: 10.1016/j.chest.2020.10.014. Epub 2020 Oct 15. Chest. 2021. PMID: 33069725 Free PMC article.
Cited by
-
Topic Modeling-Based Analysis of News Keywords Related to Patients with Diabetes during the COVID-19 Pandemic.Healthcare (Basel). 2023 Mar 28;11(7):957. doi: 10.3390/healthcare11070957. Healthcare (Basel). 2023. PMID: 37046886 Free PMC article.
-
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning.Cell Metab. 2021 Mar 2;33(3):479-498. doi: 10.1016/j.cmet.2021.01.016. Epub 2021 Jan 21. Cell Metab. 2021. PMID: 33529600 Free PMC article. Review.
-
Contributions from Mexican Flora for the Treatment of Diabetes Mellitus: Molecules of Psacalium decompositum (A. Gray) H. Rob & Brettell.Molecules. 2021 May 13;26(10):2892. doi: 10.3390/molecules26102892. Molecules. 2021. PMID: 34068304 Free PMC article. Review.
-
Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in Mexico.Cancer Med. 2022 Apr;11(8):1827-1836. doi: 10.1002/cam4.4582. Epub 2022 Feb 14. Cancer Med. 2022. PMID: 35166033 Free PMC article.
-
COVID-19 Screening by Anti-SARS-CoV-2 Antibody Seropositivity: Clinical and Epidemiological Characteristics, Comorbidities, and Food Intake Quality.Int J Environ Res Public Health. 2021 Aug 26;18(17):8995. doi: 10.3390/ijerph18178995. Int J Environ Res Public Health. 2021. PMID: 34501583 Free PMC article.
References
-
- World Health Organization Pneumonia of unknown cause – China, 5 January 2020. Accessed 30 July 2020. Available from https://www.who.int/csr/don/05-january-2020-pneumonia-of-unkown-cause-ch...
-
- Johns Hopkins Coronavirus Resource Center COVID-19 Map. Accessed 30 July 2020. Available from https://coronavirus.jhu.edu/map.html
-
- Shi Q, Zhang X, Jiang F, et al. . Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care 2020;43:1382–1391 - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical